Viela Bio (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- February 28, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $250,000,000
Company Info
- Company Description
- Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. The Company's portfolio selectively targets shared critical pathways that are the root cause of disease.
- Market
- Severe inflammation and autoimmune diseases
- Location
- Gaithersburg, MD, USA
- Coinvestors
- 6 Dimensions Capital, Boyu Capital, Hillhouse Capital Group, Sirona Capital, Temasek